Engineered IL-39 cytokine unlocks new pathways for immunotherapy
In a new preclinical study, scientists present a molecular engineering approach to modify and repurpose a cytokine named IL-39, which plays a central role in inflammation and immunity.
Read original article on The Medical News →Related news
-
HIV prevention medication is highly effective, but it can complicate blood donor screening
United Kingdom
-
Maternal vitamin A deficiency may increase risk of larger babies
United Kingdom
-
Microglia drive excessive iron transfer in Parkinson's disease models
United Kingdom
-
Hot homes cause heart strain in older Australians
United Kingdom
-
Topadur’s Phase 2a trial of TOP-N53 for systemic sclerosis-associated digital ulcers advances to next dose levels
United Kingdom
-
Elusive HIV strains cause breakthrough infections after antibody treatment ends
United Kingdom
-
Rising colorectal cancer rates prompt earlier routine screening recommendations
United Kingdom
-
Early childhood intervention crucial for treating rising eating disorders
United Kingdom